NCT00358124View on ClinicalTrials.gov

Insulin Glargine v Rosiglitazone as add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination Therapy

PHASE4CompletedINTERVENTIONAL

Enrollment

220

Participants

Timeline

Start Date

January 31, 2001

Study Completion Date

June 30, 2002

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

insulin glargine

DRUG

rosiglitazone

DRUG

metformin

Trial Locations (1)

08807

Sanofi-Aventis, Bridgewater

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT00358124 - Insulin Glargine v Rosiglitazone as add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination Therapy | Biotech Hunter | Biotech Hunter